Multiple Sclerosis Clinical Trial
Metabolic Syndrome Feasibility Study
Summary
The objective of this study is to determine whether the finger tip images captured by the EPIC ClearView device, when analyzed via the ClearView software, produce a Response Scale that characterizes trends consistent with Metabolic Syndrome identified by medical doctors.
Eligibility Criteria
Metabolic Group
Inclusion Criteria:
Sex: Male or Female
Age range: 21 to 85
Qualifying Metabolic Syndrome diagnosis(using the National Cholesterol Education Program Adult Treatment Panel (ATP) III definition)(Grundy, 2004)
Subjects will be identified as having Metabolic Syndrome if they meet at least three of the following five criteria:
Elevated waist circumference: ≥ 102 cm (≥40 inches) in men, ≥ 88 cm (≥35 inches) in women
Elevated triglycerides: ≥ 150 mg/dL (1.7 mmol/L) or on drug treatment for elevated triglycerides (examples include, but are not limited to, fibrates and nicotinic acid)
Reduced HDL cholesterol: < 40 mg/dL (1.03 mmol/L) in men or < 50 mg/dL (1.3 mmol/L) in women or on drug treatment for reduced HDL-C
Elevated blood pressure: ≥ 130 mm Hg systolic blood pressure or ≥85 mm Hg diastolic blood pressure or on antihypertensive drug treatment in a patient with a history of hypertension
Elevated fasting glucose: ≥ 100 mg/dL or on drug treatment for elevated glucose
The patient or legal representative is able to understand and provide signed consent for the procedure.
Exclusion Criteria:
Patients < 21years in age or > 85 years in age.
Inability or unwillingness to provide informed consent.
Patients with pacemakers or another electrical device implanted somewhere in their body.
Pregnant women.
Missing all or part of fingers or cuts/burns on pads of fingers
Hand tremors or involuntary oscillations of the hands that prevents clear imaging
Control Group:
Inclusion Criteria:
Sex: Male or Female
Age range: 21 to 85
Freedom from qualifying medical diagnoses (control group)
Any one of the following will exclude the subject from participation in the study
Documented current diagnosis/treatment of cancer (including Sickle Cell Disease)
Documented current diagnosis/treatment of coronary artery disease or heart attack
Documented as currently in Renal Failure (chronic or acute) or on renal dialysis
Documented current diagnosis/treatment for Hepatitis
5 .The patient or legal representative is able to understand and provide signed consent for the procedure.
Exclusion Criteria:
Patients < 21 years in age or > 85 years in age.
bility or unwillingness to provide informed consent.
Patients with pacemakers or another electrical device implanted somewhere in their body.
Pregnant women.
Missing all or part of fingers or cuts/burns on pads of fingers
Hand tremors or involuntary oscillations of the hands that prevents clear imaging
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Scottsdale Arizona, 85255, United States
Scottsdale Arizona, 85255, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.